127 related articles for article (PubMed ID: 2115074)
1. Imaging the dopamine uptake site with ex vivo [18F]GBR 13119 binding autoradiography in rat brain.
Ciliax BJ; Kilbourn MR; Haka MS; Penney JB
J Neurochem; 1990 Aug; 55(2):619-23. PubMed ID: 2115074
[TBL] [Abstract][Full Text] [Related]
2. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
Richfield EK
Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
[TBL] [Abstract][Full Text] [Related]
3. Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways.
Izenwasser S; Werling LL; Rosenberger JG; Cox BM
Neuropharmacology; 1990 Nov; 29(11):1017-24. PubMed ID: 2087254
[TBL] [Abstract][Full Text] [Related]
4. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM
J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686
[TBL] [Abstract][Full Text] [Related]
5. In vivo binding of [18F]GBR 13119 to the brain dopamine uptake system.
Kilbourn MR
Life Sci; 1988; 42(14):1347-53. PubMed ID: 3352457
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex.
Izenwasser S; Werling LL; Cox BM
Brain Res; 1990 Jun; 520(1-2):303-9. PubMed ID: 2145054
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935.
Mennicken F; Savasta M; Peretti-Renucci R; Feuerstein C
J Neural Transm Gen Sect; 1992; 87(1):1-14. PubMed ID: 1346964
[TBL] [Abstract][Full Text] [Related]
8. [3H]GBR 12935 binding to dopamine uptake sites in the human brain.
De Keyser J; De Backer JP; Ebinger G; Vauquelin G
J Neurochem; 1989 Nov; 53(5):1400-4. PubMed ID: 2795007
[TBL] [Abstract][Full Text] [Related]
9. Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR 12783.
Boulay D; Leroux-Nicollet I; Duterte-Boucher D; Naudon L; Costentin J
J Neural Transm Gen Sect; 1994; 98(3):209-15. PubMed ID: 7748521
[TBL] [Abstract][Full Text] [Related]
10. In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum.
Chagraoui A; Bonnet JJ; Protais P; Costentin J
Neurosci Lett; 1987 Jul; 78(2):175-9. PubMed ID: 3627558
[TBL] [Abstract][Full Text] [Related]
11. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
Bonnet JJ; Protais P; Chagraoui A; Costentin J
Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625
[TBL] [Abstract][Full Text] [Related]
12. Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors.
Köhler C; Hall H; Gawell L
Eur J Pharmacol; 1986 Jan; 120(2):217-26. PubMed ID: 3948920
[TBL] [Abstract][Full Text] [Related]
13. Quantitative autoradiography of 3H-nomifensine binding sites in rat brain.
Scatton B; Dubois A; Dubocovich ML; Zahniser NR; Fage D
Life Sci; 1985 Mar; 36(9):815-22. PubMed ID: 3974411
[TBL] [Abstract][Full Text] [Related]
14. Interaction of [3H]GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens.
Berger P; Elsworth JD; Arroyo J; Roth RH
Eur J Pharmacol; 1990 Feb; 177(1-2):91-4. PubMed ID: 1967129
[TBL] [Abstract][Full Text] [Related]
15. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
Vaugeois JM; Bonnet JJ; Costentin J
Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
[TBL] [Abstract][Full Text] [Related]
16. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake.
Heikkila RE; Manzino L
Eur J Pharmacol; 1984 Aug; 103(3-4):241-8. PubMed ID: 6237922
[TBL] [Abstract][Full Text] [Related]
17. In vivo binding of the dopamine uptake inhibitor [18F]GBR 13119 in MPTP-treated C57BL/6 mice.
Kilbourn MR; Mulholland GK; Sherman PS; Pisani T
Int J Rad Appl Instrum B; 1991; 18(7):803-6. PubMed ID: 1787091
[TBL] [Abstract][Full Text] [Related]
18. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
20. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
Kelly E; Jenner P; Marsden CD
J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
